Abiopharma

🔍 McCurry Jennifer Lynn (Executive)

Company: LA-Z-BOY INC (LZB)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 2,792 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,245.00 | transaction_form_type: 4
• Sold 176 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,069.00 | transaction_form_type: 4
• Sold 264 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 17,805.00 | transaction_form_type: 4
• Acquired 719 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,524.00 | transaction_form_type: 4
• Sold 204 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,320.00 | transaction_form_type: 4
• Acquired 1,994 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,314.00 | transaction_form_type: 4
• Sold 571 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 19,743.00 | transaction_form_type: 4
• Acquired 578 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,321.00 | transaction_form_type: 4
• Acquired 551 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,872.00 | transaction_form_type: 4